Clinical trial
Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
NCT00922766 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- September 30, 2010
- Enrollment
- 618 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.